**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 13623-11-5 |2,4,5-Trimethylthiazole | 99 | 237-107-9 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Stench.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
Causes skin irritation. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
Causes respiratory tract irritation. Aspiration may lead to
pulmonary edema. Can produce delayed pulmonary edema. Inhalation at
high concentrations may cause CNS depression and asphixiation.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Combustible liquid.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas. Containers may explode when heated.
Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam. Use water spray to cool fire-exposed
containers. Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Empty containers retain product
residue, (liquid and/or vapor), and can be dangerous. Keep container
tightly closed. Keep away from heat, sparks and flame. Avoid
ingestion and inhalation. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or
open flames.
Storage:
Keep away from sources of ignition. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use process enclosure,
local exhaust ventilation, or other engineering controls to control
airborne levels.
Exposure Limits
CAS# 13623-11-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear, colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 165 - 167 deg C @ 717.00mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 61 deg C ( 141.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0280g/cm3
Molecular Formula: C6H9NS
Molecular Weight: 127.20
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, sulfur oxides (SOx), including sulfur oxide
and sulfur dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 13623-11-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,4,5-Trimethylthiazole -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 13623-11-5: No information available.
Canada
CAS# 13623-11-5 is listed on Canada's DSL List.
CAS# 13623-11-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13623-11-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Monomethyl monopotassiummalonate, 98%
| 38330-80-2 |
|
4-Bromomandelic Acid, 96% (HPLC)
| 6940-50-7 |
|
Stigmasterol, 95%
| 83-48-7 |
|
2-Chloro-6-Nitrotoluene, 99%
| 83-42-1 |
|
[Tris(trimethylsilyl)]arsenide, 98%
| 17729-30-5 |
|
1-Ethylquinaldinium Iodide, 97% (titr.)
| 606-55-3 |
|
L-Aspartyl-L-Phenylalanine Methyl Ester, 98%
| 22839-47-0 |
|
Primaquine diphosphate, 99+%
| 63-45-6 |
|
Ethyl 5-Hydroxy-2-Methylindole-3- Carboxylate
| 7598-91-6 |
|
(R)-(-)-1-Amino-2-Propanol, 98+%
| 2799-16-8 |
|
N-Methylthiourea, 97%
| 598-52-7 |
|
2,3,4,5,6-Pentafluoroanisole, 97+%
| 389-40-2 |
|
Cyclohexene Oxide, 98%
| 286-20-4 |
|
5-beta-Pregnane-3-alpha,20-alpha-diol, 99%
| 80-92-2 |
|
Cyclooctene Oxide, 99%
| 286-62-4 |
|
2-(4-Methoxyphenyl)-4,6-Diphenylpyrylium Tetrafluoroborate
| 2907-13-3 |
|
Sodium Hexafluoroantimonate, 98% (Titr.)
| 16925-25-0 |
|
Ethylene/Acrylic Acid Copolymer
| 9010-77-9 |
|
4-Fluoro-2-Nitrotoluene, 98%
| 446-10-6 |
|
N-Carbethoxy-4-Piperidone, 97+%
| 29976-53-2 |
|
3-Methylhippuric acid,98+%
| 27115-49-7 |
|
Amberlite cg-400 ion-exchange resin
| 37247-87-3 |
|
3-Nitrotoluene, 99%
| 99-08-1 |
|
1,3-Diphenylguanidine, 99% (uv-vis)
| 102-06-7 |
|
2-Bromo-4-Methylaniline, 98%
| 583-68-6 |
|
2,2'-Bithiophene
| 492-97-7 |
|
5,6-Dimethylbenzimidazole, 99+%
| 582-60-5 |
|
4-Butoxyaniline, 99% (titr.)
| 4344-55-2 |
|
Alpha-Cyano-O-Tolunitrile, Tech.
| 3759-28-2 |
|
DL-Laudanosoline Hydrobromide Trihydrate, 98%
| 485-33-6 |
|
4-Chloro-6-Nitro-Meta-Cresol, 99%
| 7147-89-9 |
|
2-Butanone oxime, 99%
| 96-29-7 |
|
Hexachloropropene, 96%
| 1888-71-7 |
|
Isopropyl Chloroacetate, 99%
| 105-48-6 |
|
3-Methylpentane, 99+%
| 96-14-0 |
|
1,4-Cyclohexanedicarboxylic Acid, 96% (Titr.)
| 1076-97-7 |
|
Azoxybenzene, 97%
| 495-48-7 |
|
l-(+)-Lactic acid, lithium salt
| 27848-80-2 |
|
4-Hexylresorcinol, 99%
| 136-77-6 |
|
Tantalum (V) Chloride, 99.9%
| 7721-01-9 |
|
2,4,5-Trimethylthiazole, 99%
| 13623-11-5 |
|
Cycloheptane, 99%
| 291-64-5 |
|
Phenylglyoxal monohydrate, 97%
| 1074-12-0 |
|
Ethyl Carbazate, 97%
| 4114-31-2 |
|
bis(Methylthio)methane, 99+%
| 1618-26-4 |
|
1-Bromo-4-Tert-Butylbenzene, 97+%
| 3972-65-4 |
|
(S)-(+)-2-Amino-2-methylbutanoic acid monohydrate, 99+% (>99% e.e.)
| 0-00-0 |
|
2-Furonitrile, 99%
| 617-90-3 |
|
l-Adrenaline, 97% (titr.)
| 51-43-4 |
|
4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid, 98+%
| 60875-16-3 |
|
|